glp-1 gip dual agonist Main physiological actions of the and Dual GIP–GLP1-Receptor Agonists In The
Description
Sebastiao I, Candeias E, Santos MS, de Oliveira CR, Moreira PI, Duarte AI

If not, whats extra

This function makes it an excellent target for the treatment of type 2 diabetes (T2D) and obesity

Kirkegaard H, Bliddal M, Stvring H, Rasmussen KM, Gunderson EP, Kber L, et al
North American region is leading the GLP-1 Market

Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in nonalcoholic fatty liver disease